test

Current Funding Opportunities

Prostate Cancer Foundation 2014 PCF Global Treatment Sciences Challenge Awards

Grants of up to $1 million over 2-3 years will be awarded for research projects related to lethal prostate cancer. (PCF expects to fund 5-10 of these awards.)  Priority will be given to high risk, first-in-field, and currently unfunded projects. Funding will support the correlative research around either clinical trials of novel agents or strategies of standard of care. The foundation's emphasis is on developing or validating biomarkers that guide therapy in patients or further understanding of the mechanism by which therapies work. While the focus is on research in humans, the actual trials or treatments themselves will not be supported. Human samples are highly preferred, although at times model systems might be required to complement the understanding of an important mechanism.

Application Deadline: September 22, 2014

Learn More >> (PDF)

 

CTSA SPIRiT (Sharing Partnership for Innovative Research in Translation) Call for Ideas

The Consortium is now soliciting letters of intent (LOI) for collaborative projects in the domain of rare diseases

(http://en.wikipedia.org/wiki/Rare_Diseases_Act_of_2002). Examples of such proposals are the engagement of patients or specific populations with rare diseases from multiple sites to permit proof of concept studies of a novel or repurposed therapeutic intervention, or the recruitment of resources from multiple sites to permit more enhanced phenotyping of a rare disease than otherwise possible. Recruitment of patients from CTSA sites outside the SPIRiT consortium will be considered.

FUNDING:

Proposals must include investigators at each of the six institutions. Up to $300,000 will be provided (i.e., $50,000 per involved CTSA SPIRiT institution).

Letters of Intent should be directed to your local CTSA SPIRiT institution contact with copies to all other SPIRiT institution contacts (see below). 

LOI Deadline:

September 15, 2014 (Invitations to submit full proposals will be issued to those projects agreed upon by the SPIRiT Directors).

Learn More>>

 

Yale Spore in Skin Cancer Developmetal Research Awards

The YALE SPORE in Skin Cancer is pleased to announce the availability of DEVELOPMENTAL RESEARCH AWARDS beginning 15 September 2014 to fund projects in amounts up to $50,000 for one year (Projects may be eligible for a second year of funding, pending receipt and review of a competitive renewal application that documents unequivocal progress during the first year of funding.)
 
Developmental Research Program Awards are intended to support a broad spectrum of innovative pilot projects applicable to human skin cancer risk, prevention, diagnosis, prognosis, or treatment. To be funded, DRP projects must have promising translational research potential, i.e., direct application to human skin cancer, and there must be the expectation that they can evolve into, or be incorporated into, full projects with an unequivocal translational component funded either within this SPORE or as independent R01 (or equivalent) grants.

Detailed instructions for applications may be obtained by email from robert.tigelaar@yale.edu

Application Deadline: August 25, 2014

Learn More>>

Yale Spore in Skin Cancer Career Development Award

The YALE SPORE in Skin Cancer is pleased to announce the availability of a CAREER DEVELOPMENT AWARD beginning 15 September 2014 to provide funds of up to $60,000 for one year (recipient may be eligible for a second year of funding, pending receipt and review of a competitive renewal application that documents unequivocal progress during the first year of funding.)
 
The purpose of the Yale SPORE in Skin Cancer Career Development Program is to more clearly focus the career development of the selected individual towards clinically relevant skin cancer biology and to specifically give them the tools to enable their contributing seminal advances in this area, as well as continuity of their individual cancer research programs. It is intended that the beneficiaries of this funding will be well grounded in both the biology of the relevant skin cells and mainstream cancer research, will have distinctive skill and knowledge sets that make them unique and individually fundable and give them a recognized identity in both the traction on the cancer biology “conveyor belt.” Accordingly, it will be necessary to tailor each individual’s developmental program to his or her particular interests and needs.

Detailed instructions for applications may be obtained by email from robert.tigelaar@yale.edu

Application Deadline: August 25, 2014

Learn More>>

National Cancer Institute Outstanding Investigator Award
The NCI is pleased to announce the Outstanding Investigator Award (OIA) funding opportunity announcement.  The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for 7 years to provide funding stability.  NCI anticipates making about 50 awards annually.
 
The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques. 
 
Applications must be submitted by Institutions who have nominated a Program Director/Principal Investigator (PD/PI) with outstanding productivity in cancer research as a recipient of NCI grant(s) for at least the past 5 years. The PD/PI will be expected to commit at least 50% of his/her research activities to the OIA; the Institution will be expected to commit at least 20% salary support.

Letter of Intent Due Date  
 
Please contact Daniel DiMaio if interested in submitting a LOI from Yale Cancer Center.
Learn More >> 


Center for Cancer Research Clinical Investigator Development Program
The Center for Cancer Research (CCR), a Division of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is pleased to announce its annual call for applications for Clinical Investigator Development Program (CIDP). This is an exciting training opportunity intended for physicians interested in dedicating their careers to clinical research. Candidates may be U.S. citizens, permanent residents or possess (or be eligible for) the appropriate work visa and must have successfully completed subspecialty training at a U.S.-accredited institution in appropriate fields.
Application Deadline: October 30, 2014
Learn More >>

Yale Cancer Center/Smilow Cancer Hospital at Yale-New Haven Grants for Small Projects to Improve Patient Care Grants for Small Projects to Improve Patient Care
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund.  Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff.  In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.

Grant Details
Amount: $2,500 to $5,000 each
Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven
Sponsorship: Member of Yale Cancer Center
Application: Limited to 3 pages, typed, double spaced; plus budget with justification   (3 copies)
            Application sheet: Project Due Date
            Project Description
            Budget 
            Budget Justification
Submit to Renee Gaudette: renee.gaudette@yale.edu
For questions, contact Dr. Ruth McCorkle by email: ruth.mccorkle@yale.edu

Application>>

AGA Foundation - 2014 Funderburg Research Award in Gastric Cancer
The American Gastroenterological Association is inviting applications for the 2014 Funderburg Research Award. The award is designed to support an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology, regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair), inflammation (including Helicobacter pylori) as precancerous lesions, genetics of gastric carcinoma, oncogenes in gastric epithelial malignancies, epidemiology of gastric cancer, etiology of gastric epithelial malignancies, or clinical research in the diagnosis or treatment of gastric carcinoma. Please note, AGA membership is required at the time of application submission. Funding up to $100,000 over 2 years.
Application Deadline: August 29, 2014
Learn More >>  
    

Gilead Sciences Research Scholars Program

The award provides financial support to 2 junior faculty researchers for a 2-year period up to $130,000.

Application Deadline: September 5, 2014

Learn More >>